Form 4: Pediatrix Medical Group Director Laura Linynsky Reports Acquisition of Shares

Director Laura Linynsky reported the acquisition of 11,427 shares of Pediatrix Medical Group, Inc. common stock on May 8, 2025, as part of an annual equity award.

Summary

• On May 8, 2025, Laura Linynsky, a director of Pediatrix Medical Group, Inc., acquired 11,427 shares of common stock.
• These shares were granted as restricted shares under the company's Amended and Restated 2008 Incentive Compensation Plan, as part of an annual equity award.
• The shares will vest on May 8, 2026.
• Following the transaction, Linynsky beneficially owns 42,232 shares of Pediatrix Medical Group, Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally seen as a positive sign, indicating confidence in the company's prospects. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• The acquisition of shares by a director signals confidence in the company's future.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.

Key Dates

Keywords

Pediatrix Medical Group, Laura Linynsky, Director, Share Acquisition, Form 4, Beneficial Ownership, Equity Award, Restricted Shares, Vesting